Journal article icon

Journal article

A role for Dicer in immune regulation

Abstract:
MicroRNAs (miRNAs) belong to an abundant class of highly conserved small (22nt) non-coding RNAs. MiRNA profiling studies indicate that their expression is highly cell type-dependent. DICER1 is an essential RNase III endoribonuclease for miRNA processing. Hematopoietic cell type- and developmental stage-specific Dicer1 deletion models show that miRNAs are essential regulators of cellular survival, differentiation and function. For instance, miRNA deficiency in hematopoietic stem cells and progenitors of different origins results in decreased cell survival, dramatic developmental aberrations or dysfunctions in mice. We recently found that homozygous Dicer1 deletion in myeloid-committed progenitors results in an aberrant expression of stem cell genes and induces a regained self-renewal capacity. Moreover, Dicer1 deletion causes a block in macrophage development and myeloid dysplasia, a cellular condition that may be considered as a preleukemic state. However, Dicer1-null cells do not develop leukemia in mice, indicating that depletion of miRNAs is not enough for tumorigenesis. Surprisingly, we found that heterozygous Dicer1 deletion in myeloid-committed progenitors, but not Dicer1 knockout, collaborates with p53 deletion in leukemic progression and results in various types of leukemia. Our data indicate that Dicer1 is a haploinsufficient tumorsuppressor in hematopoietic neoplasms, which is consistent with the observed downregulation of miRNA expression in human leukemia samples. Here, we review the various hematopoietic specific Dicer1 deletion mouse models and the phenotypes observed within the different hematopoietic lineages and cell developmental stages. Finally, we discuss the role for DICER1 in mouse and human malignant hematopoiesis
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1084/jem.20061692

Authors

More by this author
Role:
Author
ORCID:
0000-0001-6783-0509
More by this author
Role:
Author
ORCID:
0000-0002-8609-8146
More by this author
Role:
Author
ORCID:
0000-0001-9131-5849
More by this author
Role:
Author
ORCID:
0000-0003-1163-8117


Publisher:
Rockefeller University Press
Journal:
Journal of Experimental Medicine More from this journal
Volume:
203
Issue:
11
Pages:
2519-2527
Publication date:
2006-10-23
DOI:
EISSN:
1540-9538
ISSN:
0022-1007


Language:
English
Keywords:
Pubs id:
2373778
Local pid:
pubs:2373778
Source identifiers:
W2118694755
Deposit date:
2026-02-15
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP